期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
便通胶囊对比芪蓉润肠口服液治疗抗精神病药物所致药源性便秘的临床疗效研究 被引量:9
1
作者 佟琦媛 王新 《世界中医药》 CAS 2018年第2期363-365,369,共4页
目的:对比观察便通胶囊和芪蓉润肠口服液治疗抗精神病药物所致药源性便秘的临床疗效与安全性。方法:选取2014年10月至2016年08月北京市怀柔区中医医院收治的精神障碍患者100例,按照随机数字表法,随机分为2组,对照组和观察组。所有患者... 目的:对比观察便通胶囊和芪蓉润肠口服液治疗抗精神病药物所致药源性便秘的临床疗效与安全性。方法:选取2014年10月至2016年08月北京市怀柔区中医医院收治的精神障碍患者100例,按照随机数字表法,随机分为2组,对照组和观察组。所有患者备用治疗便秘药物,当便秘发生时给予及时治疗,对照组给予芪蓉润肠口服液,观察组给予便通胶囊,随访和观察期为1年。观察便秘发生率、便秘症状评分、便秘总有效率、平均服药天数和不良反应。结果:2组便秘发生率比较,差异无统计学意义(P>0.05);观察组因为治疗3 d,便秘仍未缓解而退出研究者显著少于对照组(P<0.05);观察组便秘症状评分、平均服药天数均显著低于对照组(P<0.05),观察组愈显率显著高于对照组(P<0.05);2组总不良反应发生率比较,差异无统计学意义(P>0.05)。结论:便通胶囊和芪蓉润肠口服液均是治疗抗精神病药物所致便秘的有效药物,但便通胶囊疗效与安全性更好,值得临床推广使用。 展开更多
关键词 抗精神病物 药源性便秘 便通胶囊 芪蓉润肠口服液
下载PDF
生津润燥液治疗精神药物所致口干对照研究
2
作者 袁国桢 黄寅平 +1 位作者 赵景芳 龚金兴 《临床精神医学杂志》 2000年第3期189-189,共1页
关键词 生津润燥液 治疗 精神病 口干
下载PDF
~1H and ^(13)C NMR Assignments for Amlodipine and Risperidone
3
作者 杨春晖 李勤 +2 位作者 刘雪辉 赵兴凯 崔育新 《Journal of Chinese Pharmaceutical Sciences》 CAS 2004年第1期49-52,共4页
Aim To investigate the NMR spectroscopy of amlodipine and risperidone.Methods 1D NMR and 2D NMR experimental techniques of gCOSY, gHSQC and gHMBC were wsed. Results Theassignments of the ~1H and ^(13) C NMR data for t... Aim To investigate the NMR spectroscopy of amlodipine and risperidone.Methods 1D NMR and 2D NMR experimental techniques of gCOSY, gHSQC and gHMBC were wsed. Results Theassignments of the ~1H and ^(13) C NMR data for the two drugs were performed and confirmed by theevidence of J_(HF) and J_(CF). Conclusion The structures of amlodipine and risperidone wereconfirmed by careful analysis of regular 1D and 2D NMR spectroscopy. 展开更多
关键词 NMR ASSIGNMENT fluorine coupling AMLODIPINE RISPERIDONE
下载PDF
Role of antipsychotics for treating behavioral and psychological symptoms of dementia 被引量:2
4
作者 Kai Zhen Yap Sui Yung Chan 《World Journal of Pharmacology》 2014年第4期174-185,共12页
Over the past three decades, concerns about the high prevalence of antipsychotic use in the nursing homes (NHs) for the management of behavioral and psychological symptoms of dementia continue to be emphasized and i... Over the past three decades, concerns about the high prevalence of antipsychotic use in the nursing homes (NHs) for the management of behavioral and psychological symptoms of dementia continue to be emphasized and intervened by many. However, despite the numerous side effects and the recent blackbox warning by the United States Food and Drug Administration about the increased risks for stroke and sudden death associated with the use of antipsychotics in dementia, the preva-lence of antipsychotic use in NHs remains high. While the use of antipsychotics appeared to have modest effcacy in reducing symptoms of aggression and psychosis in dementia, there is insuffcient evidence to routinely rec-ommend the use of alternative psychopharmacological treatments for these symptoms. Hence, clinicians have to balance the safety warnings against the need to treat these symptoms in order to prevent harm to the resident that may result from his/her dangerous behaviors. Although the use of antipsychotics may be warranted in some cases, organizational, resource and training support should be provided to encourage and equip NH staff to participate in interventions so as to minimize inappropriate use of these medicines in NHs. This review will discuss the place in therapy, the trend and appropriateness of antipsychotic use in NHs, as well as the effectiveness of current and future strategies for reducing antipsychotic use in the NHs. 展开更多
关键词 Antipsychotic agents Psychotropic drugs Prescribing appropriateness DEMENTIA Behavioral and psychological symptoms of dementia Nursing homes
下载PDF
Aging effects on QT interval: Implications for cardiac safety of antipsychotic drugs 被引量:1
5
作者 Simon W. Rabkin 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2014年第1期20-25,共6页
Objectives To explore the effect of aging on cardiac toxicity specifically the interaction of age and antipsychotic drugs to alter the QT interval. Methods The Medline databases were searched using the OvidSP platform... Objectives To explore the effect of aging on cardiac toxicity specifically the interaction of age and antipsychotic drugs to alter the QT interval. Methods The Medline databases were searched using the OvidSP platforms with the search strategy: "QT interval" or "QT" and "age" or "aging". The entry criteria were: over 10,000 apparently healthy individuals with data on both sexes; QT interval corrected for heart rate (QTc) and an expression of its variance for multiple age decades extending into the older ages. Results QTc increased in duration with increasing age. Considering a modest one SD increment in QTc in the normal population, the addition of Chlorpromazine produced a QTc on average greater than 450 ms for ages 70 years and older. Risperidone, that did not on average alter QTc, would be expected to produce a QTc of 450 ms in persons in their mid 70 years under some circumstances. QTc prolongation 〉 500 ms with antipsychotic drugs is more likely for persons with QTc initially at the 99th percentile. It may occur with Haloperidol which does not on average alter QTc. Conclusions The range of values for the QT interval in apparently normal older men or women, when combined with the range of expected QT interval changes induced by antipsychotic drugs, can readily be associated with prolonged QTc. Individuals with QTc at the 99th percentile may have serious QTc prolongation with antipsychotic drugs even those that are not usually associated with QTc prolongation. 展开更多
关键词 Cardiac safety Antipsychotic drugs Psychotropic drugs QT interval AGING
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部